These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1913620)
1. Ornithine decarboxylase induction in mouse kidney as indicator of renal damage. Differential nephrotoxic effect of anticancer antifolate drugs. Manteuffel-Cymborowska M; Chmurzyńska W; Grzelakowska-Sztabert B Cancer Lett; 1991 Sep; 59(3):237-41. PubMed ID: 1913620 [TBL] [Abstract][Full Text] [Related]
2. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate. Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804 [TBL] [Abstract][Full Text] [Related]
3. Catecholamines participate in the induction of ornithine decarboxylase gene expression in normal and hyperplastic mouse kidney. Dudkowska M; Manteuffel-Cymborowska M; Chmurzyńska W; Grzelakowska-Sztabert B Biochim Biophys Acta; 1999 May; 1454(1):71-9. PubMed ID: 10354516 [TBL] [Abstract][Full Text] [Related]
4. Cross-talk between steroid-receptor-mediated and cell-membrane-receptor-mediated signalling pathways results in the in vivo modulation of c-Met and ornithine decarboxylase gene expression in mouse kidney. Dudkowska M; Stachurska A; Chmurzyska W; Grzelakowska-Sztabert B; Manteuffel-Cymborowska M Biochem J; 2001 Jan; 353(Pt 2):317-23. PubMed ID: 11139396 [TBL] [Abstract][Full Text] [Related]
5. Polyamines in testosterone-induced hypertrophic and antifolate-induced hyperplastic mouse kidney. Differential effect of alpha-difluoromethylornithine. Manteuffel-Cymborowska M; Chmurzyńska W; Grzelakowska-Sztabert B Biochim Biophys Acta; 1993 Sep; 1182(2):133-41. PubMed ID: 8357843 [TBL] [Abstract][Full Text] [Related]
6. Arginine and ornithine metabolizing enzymes in testosterone-induced hypertrophic mouse kidney. Manteuffel-Cymborowska M; Chmurzyńska W; Peska M; Grzelakowska-Sztabert B Int J Biochem Cell Biol; 1995 Mar; 27(3):287-95. PubMed ID: 7780833 [TBL] [Abstract][Full Text] [Related]
7. Polyglutamation of the antifolate anticancer drug N10-propargyl-5,8-dideazafolic acid (CB 3717) in the mouse. Manteuffel-Cymborowska M; Sikora E; Grzelakowska-Sztabert B Anticancer Res; 1986; 6(4):807-12. PubMed ID: 2875688 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939 [TBL] [Abstract][Full Text] [Related]
10. Early DNA damage induced in cells exposed to N10-propargyl 5,8-dideazafolic acid (CB 3717) or methotrexate. Lorico A; Toffoli G; Boiocchi M; Erba E; Broggini M; Rappa G; D'Incalci M Biochem Pharmacol; 1988 May; 37(9):1875-6. PubMed ID: 3377859 [No Abstract] [Full Text] [Related]
11. Nuclear and membrane receptor-mediated signalling pathways modulate polyamine biosynthesis and interconversion. Grzelakowska-Sztabert B; Dudkowska M; Manteuffel-Cymborowska M Biochem Soc Trans; 2007 Apr; 35(Pt 2):386-90. PubMed ID: 17371283 [TBL] [Abstract][Full Text] [Related]
12. The renal effects of N10-propargyl-5,8-dideazafolic acid (CB3717) and a non-nephrotoxic analogue ICI D1694, in mice. Jodrell DI; Newell DR; Morgan SE; Clinton S; Bensted JP; Hughes LR; Calvert AH Br J Cancer; 1991 Nov; 64(5):833-8. PubMed ID: 1931603 [TBL] [Abstract][Full Text] [Related]
13. Dose dependent retention and polyglutamation of N10-propargyl-5,8-dideazafolic acid (CB 3717) in the tumour-bearing mouse. Manteuffel-Cymborowska M; Kaminska B; Grzelakowska-Sztabert B Anticancer Res; 1988; 8(4):791-6. PubMed ID: 3178167 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate. Li WW; Tong WP; Bertino JR Clin Cancer Res; 1995 Jun; 1(6):631-6. PubMed ID: 9816025 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Lorico A; Toffoli G; Boiocchi M; Erba E; Broggini M; Rappa G; D'Incalci M Cancer Res; 1988 Apr; 48(8):2036-41. PubMed ID: 3349474 [TBL] [Abstract][Full Text] [Related]
16. Identification of a reduced folate/methotrexate carrier in human KB-cells expressing high levels of membrane associated folate binding protein. Westerhof GR; Schornagel JH; Rijnboutt S; Pinedo HM; Jansen G Adv Exp Med Biol; 1993; 338():771-4. PubMed ID: 8304226 [No Abstract] [Full Text] [Related]
17. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
18. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y; Ohnuma T Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841 [TBL] [Abstract][Full Text] [Related]
19. Antifolate/folate-activated HGF/c-Met signalling pathways in mouse kidneys-the putative role of their downstream effectors in cross-talk with androgen receptor. Dudkowska M; Bajer S; Jaworski T; Zielińska J; Manteuffel-Cymborowska M; Grzelakowska-Sztabert B Arch Biochem Biophys; 2009 Mar; 483(1):111-9. PubMed ID: 19135973 [TBL] [Abstract][Full Text] [Related]
20. Effects of lipoxygenase and cyclooxygenase inhibitors on the induction of ornithine decarboxylase by 12-O-tetradecanoylphorbol-13-acetate and isoproterenol in mouse tissues in vivo. Uzumaki H; Yamamoto S; Kato R Carcinogenesis; 1986 Feb; 7(2):289-94. PubMed ID: 3081271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]